Ziritaxestat, CAS [[1628260-79-6]]

Produktübersicht

• Artikelname: Ziritaxestat, CAS [[1628260-79-6]]
• Artikelnummer: BYT-ORB1303261
• Hersteller Artikelnummer: orb1303261
• Alternativnummer: BYT-ORB1303261-1, BYT-ORB1303261-10, BYT-ORB1303261-100, BYT-ORB1303261-200, BYT-ORB1303261-25, BYT-ORB1303261-5, BYT-ORB1303261-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: autotaxin, Inhibitor, GLPG1690, GLPG-1690, GLPG 1690, inhibit, Ziritaxestat, Phosphodiesterase (PDE), phosphodiesterase

Produktbeschreibung

Ziritaxestat (GLPG1690) is a small molecule autotaxin inhibitor. It has been investigated in a Phase 2 clinical trial for idiopathic pulmonary fibrosis (IPF). Preclinical studies in vitro and in animal models have demonstrated its role in targeting the LPA pathway relevant to fibrotic diseases.

Produkteigenschaften

• Molekulargewicht: 588.7
• Reinheit: 99.85% (May vary between batches)
• CAS Nummer: [1628260-79-6]
• Formel: C30H33FN8O2S
• Target-Kategorie: PDE

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.4 mM),DMSO:50 mg/mL (84.93 mM),H2O:< 0.1 mg/mL (insoluble)